The inaugural Consumer Healthcare (CHC) Safety Roundtable, hosted by Navitas pvnetworks and led by industry leaders Dr. Latika Sharma, MBBS, MD, Ben P...
As the world observes World Parkinson’s Day on April 11th, a day dedicated to raising awareness about Parkinson’s disease and honouring ...
On April 7, 2025, we join the World Health Organisation, under the banner of Healthy beginnings, hopeful futures. The World Health Day 2025 campaign u...
The pharmaceutical industry is experiencing a paradigm shift in medical writing, driven by artificial intelligence (AI), structured content authoring,...
The pharmaceutical industry is undergoing a significant transformation driven by digital innovation and artificial intelligence (AI). It has become in...
The global generics market is on an accelerated growth path, with the U.S. leading the way, projected to surpass USD 508.37 billion by 2034 at a CAGR ...
Ensuring Compliance with the Windsor Framework The Windsor Framework is now implemented, transforming the regulatory landscape for pharmaceutical comp...
Phase 1 clinical trials are the foundation of clinical drug development, marking the transition from laboratory research to human testing. These first...
In January 2025, we were honoured with the EcoVadis Bronze Medal for our sustainability initiatives. This recognition affirms our dedication to sustai...
Every year, February 11 marks the International Day of Women and Girls in Science, a day dedicated to recognizing the contributions of women in scienc...
At Navitas Life Sciences, we stand as a leading oncology CRO, delivering cutting edge solutions that optimize trial design, enhance patient recruitmen...
What is a CRO? A Contract Research Organization (CRO) is a strategic partner to pharmaceutical, biotechnology, and medical device companies, providing...
Glaucoma remains a leading cause of irreversible blindness worldwide, affecting millions of people and posing significant challenges for healthcare sy...
The US Food and Drug Administration (FDA) recently provided a draft guidance on the application of artificial intelligence (AI) in regulatory decision...
The clinical trials landscape in 2025 is shaped by technological advancements, regulatory shifts, and a growing demand for innovative therapies. In ou...
Navitas Life Sciences has been at the forefront, sharing knowledge and driving impactful discussions. Here’s a roundup of our top 10 blogs for ...
In a recent episode of The Gens & Associates Podcast, host Steve Gens engaged in a compelling discussion with Navitas Life Sciences' leaders: Mart...
As a leading CRO, Navitas Life Sciences consistently drives innovation in clinical trials, including oncology research, data sciences, regulatory affa...
The second Medical Roundtable provided a rich platform for industry leaders to discuss strategies, innovations, and challenges in medical writing outs...
In the pharmaceutical industry, where data drives innovation and ensures regulatory compliance, sound data governance practices are critical. This is ...